Business Sweden has featured VERIGRAFT in a new article highlighting the company’s international investment journey, continued clinical development and ambitions for future growth.
The article explores the importance of long-term international investment, Sweden’s strong life science ecosystem and the role of Business Sweden in supporting VERIGRAFT’s development.
Our CEO, Petter Björquist, also shares his perspective on Sweden’s growing expertise and capabilities in advanced therapies.